Clinical trial
Helicobacter Eradication Relief of Dyspeptic Symptoms
NCT00404534 · Hospital de Clinicas de Porto Alegre, Other · Completed
Key facts
| NCT number | NCT00404534 |
|---|---|
| Title | Helicobacter Eradication Relief of Dyspeptic Symptoms |
| Official title | Dyspeptic Symptoms Evolution After Eradication of Helicobacter Pylori in Patients With Different Endoscopic Findings: a Randomized Double-blind Placebo-controlled Clinical Trial With 12 Months of Follow-up |
| Acronym | HEROES-12 |
| Lead sponsor | Hospital de Clinicas de Porto Alegre, Other |
| Collaborators | Aché Laboratórios Farmacêuticos Ltda Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Functional Dyspepsia |
| Intervention type | Drug |
| Interventions | Amoxicillin, Clarythromycin, Omeprazole for ten days |
| Enrollment | 407 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Nov 28, 2006 |
| Last update posted | Mar 1, 2018 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: